Fig. 1From: Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series studyChanges in rheumatoid arthritis-related parameters after the initiation of allergen immunotherapy (AIT). A simplified disease activity score (SDAI). B matrix metaroproteinase-3 (MMP-3). C c-reactive protein (CRP). For all parameters, comparisons were made between baseline and each of the following time points with the Wilcoxon signed rank test: 1Â month, 2Â months, 3Â months, 6Â months, 9Â months, 12Â months, 15Â months, 18Â months, 21Â months, and 24Â months. Each gray line corresponds to an individual value; the median and interquartile ranges are indicated by bold black lines. Two patients had worsening disease activity, which is indicated by the arrowsBack to article page